"official" 2 year anniversary of covid in the US

1,683 Views | 17 Replies | Last: 4 yr ago by Secolobo
Post removed:
by user
Kvetch
How long do you want to ignore this user?
It's also just about the 2 year anniversary of me living a normal life and not caring.
Squadron7
How long do you want to ignore this user?
Wuhan? Wuhan, China you say?

Is that why they call this the Wuhan Chinese virus?

Or should, anyway.
FriscoKid
How long do you want to ignore this user?
Trillions of dollars later and people are still believing that a mask will save them.
Secolobo
How long do you want to ignore this user?
Gosh, it's almost like it was planned....

Nancy Pelosi explains what Democrats gained by holding onto the articles of impeachment


Pelosi Announces House Will Deliver Article of Impeachment to Senate on January 25
e=mc2
How long do you want to ignore this user?
We've had waaaaaaaaay more than 63,397,935 cases.
flakrat
How long do you want to ignore this user?
Rapier108
How long do you want to ignore this user?
It was here in early December 2019 at the latest.
Secolobo
How long do you want to ignore this user?
A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC Staff
Post removed:
by user
AgResearch
How long do you want to ignore this user?
Rapier108 said:

It was here in early December 2019 at the latest.
Agree. That's when I likely had it based on the odd symptoms.
thirdcoast
How long do you want to ignore this user?
Cromagnum
How long do you want to ignore this user?
FriscoKid
How long do you want to ignore this user?
Secolobo said:

A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC Staff
Quote:

June 29 Gilead Sets Price for Remdesivir at $3120

Gilead Sciences sets a price for remdesivir, which can shorten hospitalization stays for patients with COVID-19, at $520 a vial. With a treatment course of 6 vials, the typical treatment course will be $3120 per patient for people covered with private insurance. Critics of the price point are quick to point out that taxpayers funded the COVID-19 remdesivir trial through the National Institute of Allergy and Infectious Diseases.
Quote:

August 24 Remdesivir's Clinical Benefits Questioned

A global, multicenter study finds that the antiviral drug remdesivir had little effect on patients hospitalized with COVID-19. The findings, published in JAMA, indicate there were no significant differences in duration of supplemental oxygen or hospitalization between the intervention group given remdesivir and the control group given standard care.
...and it's still standard care if you end up in the hospital.
FriscoKid
How long do you want to ignore this user?
Secolobo said:

A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC Staff
Quote:

November 16 Moderna Reveals Vaccine Efficacy Results

The positive vaccine news continues with Moderna's announcement that its experimental vaccine reduces the risk of COVID-19 infection by 94.5% in participants who received it. Like Pfizer's vaccine, the Moderna vaccine works using mRNA, an innovative approach that has not yet been used in approved vaccines against any disease.
That's impossible! We keep on being told that the vaccine was never promoted to prevent infections. It was always designed to just make you less sick!
GCRanger
How long do you want to ignore this user?
Here is the thread that kicked it all off.

https://texags.com/forums/16/topics/3090341/1
No Spin Ag
How long do you want to ignore this user?
GCRanger said:

Here is the thread that kicked it all off.

https://texags.com/forums/16/topics/3090341/1


Ah yes, back when the interwebs took to making fun of it with Corona beer boxes. Good times.
Secolobo
How long do you want to ignore this user?
FriscoKid said:

Secolobo said:

A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC Staff
Quote:

June 29 Gilead Sets Price for Remdesivir at $3120

Gilead Sciences sets a price for remdesivir, which can shorten hospitalization stays for patients with COVID-19, at $520 a vial. With a treatment course of 6 vials, the typical treatment course will be $3120 per patient for people covered with private insurance. Critics of the price point are quick to point out that taxpayers funded the COVID-19 remdesivir trial through the National Institute of Allergy and Infectious Diseases.
Quote:

August 24 Remdesivir's Clinical Benefits Questioned

A global, multicenter study finds that the antiviral drug remdesivir had little effect on patients hospitalized with COVID-19. The findings, published in JAMA, indicate there were no significant differences in duration of supplemental oxygen or hospitalization between the intervention group given remdesivir and the control group given standard care.
...and it's still standard care if you end up in the hospital.
Yeah, And I received it. Makes my stomach turn.
I'm sure I'll start seeing on tv and hearing on radio and start getting phone calls about the pending class action lawsuit…
I kept wondering why they were taking blood samples and monitoring my kidneys.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.